DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Terbinafine hydrochlorideis the generic ingredient in three branded drugs marketed by Glaxosmithkline, Novartis, Taro, Glaxosmithkline Cons, Aurobindo Pharma, Breckenridge Pharm, Chartwell, Cipla, Dr Reddys Labs Inc, Gedeon Richter Usa, Glenmark Generics, Harris Pharm, Heritage Pharma, Invagen Pharms, Mylan, Orchid Hlthcare, Roxane, and Wockhardt, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.
There are twenty-seven drug master file entries for terbinafine hydrochloride. Thirty-six suppliers are listed for this compound. There are four tentative approvals for this compound.
Recent Clinical Trials for terbinafine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|IQVIA Biotech||Phase 2|
|Blueberry Therapeutics||Phase 2|
|United Laboratories||Phase 2|
Generic filers with tentative approvals for TERBINAFINE HYDROCHLORIDE
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for terbinafine hydrochloride
|Drug Class||Allylamine Antifungal |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.